Shop for $75 or more and get 13% off
  • Danielle Jolla, United States says, "I love your online pharmacy Because of your quick shipping and reasonable prices."
  • Jill Barrella, United States says, "Seemed easy to purchase, reasonable prices. Good customer service when I used it."
  • Brian Pavey, United States says, "I am very satisfied with IDM and plan on making more purchases in the future. IDMs prices are low which makes it very compelling to use over conventional pharmacies with high copays and more restrictions continually implemented."
  • Eric Gonzales, United States says, "The website is very user friendly, there is a lot of variety and checking out was easy."
  • Albert Martinez, United States says, "Very organized and efficient concerning delivery and products are great. Very satisfied, impressed with delivery and product."
  • Natalie Wallace, United States says, "I absolutely love getting my medications at a great price and I always get that here. And I recommend this site to my family and friends."
    • Just look at what our Tens of Thousands of Satisfied Customers say about us
    Ask our pharmacist, if you have any questions related to your medications
    Click to find International Shipping charges at our pharmacy.
    Shop & Earn @ InternationalDrugMart
    Easy and secure shopping @ InternationalDrugMart.com.
    Get your instant Coupon now!
    Price challenge
    You can find the latest happening of our pharmacy Visit to discuss on various diseases and conditions
    Follow us on Twitter

      Nicholas Pirmal acquires Avecia Pharmacueitcals in UK

      Posted AtExpressPharmaPulse.com

      Nicholas Piramal India (NPIL) announced the acquisition of Avecia Pharmaceuticals, UK for a consideration of Ã,£9.5 million. The consideration is inclusive of funding the business' UK pension fund deficit of between Ã,£8-9 million. The transaction completion is subject to required regulatory and other approvals.

      This acquisition is NPIL's second M&A transaction in the UK after its acquisition of Rhodia's Inhalation Anaesthetics business in December 2004. The transaction is in the nature of a share purchase on liabilities and cash-free basis. It includes working capital of Ã,£8.8 million.

      Avecia Pharmaceuticals is a global custom manufacturing player focused on providing custom chemical synthesis and manufacturing services for the innovator pharmaceutical and biotechnology companies. It had consolidated sales of Ã,£36.1 million (Rs 2.9 billion) in 2004.

      Avecia Pharmaceuticals is part of the UK-based Avecia Group. Private equity funds managed by Cinven and Investcorp International acquired Avecia Group from AstraZeneca in 1999.

      The acquisition of Avecia Pharmaceuticals marks the start of a new wave of restructuring within the global custom manufacturing industry.

      Players in Europe and North America, driven by their access to technologies and customers, have historically dominated the $15 billion industry. However, over the last few years, increased cost pressure and downturn in the pharma industry has put them under pressure. Experts believe that the winning custom manufacturers of the future will have a strong manufacturing base in India with technology and early-phase beachheads in North America and Europe.

      This transaction is the first step in NPIL's strategy of establishing global footprint for its custom manufacturing business. The reconfigured asset base will include access to leading early phase assets, including nearly 100 early-phase and launched products.

      November 23, 2005


       

      Share this Article!

    Back to top^